• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Gyrus

Anonymous board for Gyrus
Replies
1
Views
2K
anonymous
Replies
5
Views
9K
anonymous
Replies
106
Views
54K
Anonymous
Replies
20
Views
15K
Anonymous
Replies
10
Views
10K
Anonymous
Replies
7
Views
5K
Anonymous
ENT
Replies
2
Views
4K
Anonymous
Replies
8
Views
6K
Anonymous
Replies
28
Views
13K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
9
Views
5K
Anonymous
Replies
3
Views
6K
Anonymous
Replies
9
Views
6K
Anonymous
Replies
5
Views
5K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
11
Views
6K
Anonymous